DCTD Programs
Last Updated: 08/26/2020
Validated Assays, Specimen Handling Procedures and Reagent Sources for Poly-Adenosyl Ribose (PAR) Immunoassay
The PAR Immunoassay has been developed to measure the effect of PARP inhibitors and/or chemotherapeutic agents on PAR levels in a variety of biospecimen types, including peripheral blood mononuclear cells (PBMCs) and tumor biopsies.
- Solid Tumor Assessment
- Liquid Tissue Assessment
- Assay Training and Key Reagent Support
- Quality Control & Troubleshooting Guide
- NCI Publications
- Biomarkers FAQ
Please email any questions or comments to PDinfo@mail.nih.gov.